Corrigendum to: Alterations of na€ıve and memory B-cell subsets are associated with risk of rejection and infection in heart recipients (Transplant International, (2013), 26, (800-812), 10.1111/tri.12131);Alterations of naïve and memory B-cell subsets are associated with risk of rejection and infection in heart recipients

Transplant International

Volumn 26, Issue 8, 2013, Pages 800-812

  Lanio, Nallibe ^a   Sarmiento, Elizabeth ^a   Gallego, Antonio ^a   Calahorra, Leticia ^a   Jaramillo, María ^a   Navarro, Joaquin ^a   Palomo, Jesus ^a   Fernandez Yañez, Juan ^a   Ruiz, Manuel ^a   Fernandez Cruz, Eduardo ^a   Carbone, Javier ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

flow cytometry; heart transplantation; immune monitoring; infection; lymphocyte subsets; rejection

Indexed keywords

B CELL ACTIVATING FACTOR; COTRIMOXAZOLE; CYCLOSPORIN; DACLIZUMAB; GANCICLOVIR; ITRACONAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NORFLOXACIN; NYSTATIN; PREDNISONE; TACROLIMUS;

AGED; ARTICLE; ASPERGILLOSIS; CARDIAC GRAFT REJECTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; INFECTION; MALE; MEMORY CELL; PRIORITY JOURNAL;

EID: 84880261178     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/tri.12815     Document Type: Erratum

References (35)

1. Stehlik J, Edwards LB, Kucheryavaya AY, et al,. The Registry of the international Society for Heart and Lung Transplantation: Twenty-eighth Adult Heart Transplant Report-2011. J Heart Lung Transplant 2011; 30: 1078.
2. Carbone J, del Pozo N, Gallego A, Sarmiento E,. Immunological risk factors for infection after immunosuppressive and biologic therapies. Expert Rev Anti Infect Ther 2011; 9: 405.
3. Calarota SA, Zelini P, De Silvestri A, et al,. Kinetics of T-lymphocyte subsets and posttransplant opportunistic infections in heart and kidney transplant recipients. Transplantation 2012; 93: 112.
4. Blanco-García RM, Lõpez-Álvarez MR, Garrido IP, et al,. CD28 and KIR2D receptors as sensors of the immune status in heart and liver transplantation. Hum Immunol 2011; 72: 841.
5. Chen M, Mohtize M, Matteï MF, et al,. Reduced levels of both circulating CD4+ CD25+ CD127(low/neg) and CD4+ CD8(neg) invariant natural killer regulatory T cells in stable heart transplant recipients. Clin Exp Immunol 2011; 163: 104.
6. Blanco-Garcia RM, Lõpez-Alvarez MR, Pascual-Figal DA, et al,. Expression of HLA molecules on peripheral blood lymphocytes: a useful monitoring parameter in cardiac transplantation. Transplant Proc 2007; 39: 2362.
7. Creemers P, Brink J, Wainwright H, Moore K, Shephard E, Kahn D,. Evaluation of peripheral blood CD4 and CD8 lymphocyte subsets, CD69 expression and histologic rejection grade as diagnostic markers for the presence of cardiac allograft rejection. Transpl Immunol 2002; 10: 285.
8. Weigel G, Griesmacher A, Karimi A, Zuckermann AO, Grimm M, Mueller MM,. Effect of mycophenolate mofetil therapy on lymphocyte activation in heart transplant recipients. J Heart Lung Transplant 2002; 21: 1074.
9. Zegleń S, Łaszewska A, Wojarski J, et al,. Lymphocyte subtypes CD3 +, CD19 +, CD16 + CD56 +, CD4 +, CD8 +, and CD3 + HLA-DR+ in peripheral blood obtained from patients after thoracic organ transplantation. Transplant Proc 2011; 43: 3055.
10. Wehr C, Kivioja T, Schmitt C, et al,. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 2008; 111: 77.
11. Lanio N, Sarmiento E, Gallego A, Carbone J,. Immunophenotypic profile of T cells in common variable immunodeficiency: is there an association with different clinical findings? Allergol Immunopathol (Madr) 2009; 37: 14.
12. Muñoz P, Rodríguez C, Bouza E, et al,. Risk factors of invasive aspergillosis after heart transplantation: protective role of oral itraconazole prophylaxis. Am J Transplant 2004; 4: 636.
13. Menard LC, Minns LA, Darche S, et al,. B cells amplify IFN-gamma production by T cells via a TNF-alpha-mediated mechanism. J Immunol 2007; 179: 4857.
14. Stewart S, Winters GL, Fishbein MC, et al,. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005; 24: 1710.
15. Berry GJ, Angelini A, Burke MM, et al,. The ISHLT working formulation for pathologic diagnosis of antibody-mediated rejection in heart transplantation: evolution and current status (2005-2011). J Heart Lung Transplant 2011; 30: 601.
16. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM,. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16: 128.
17. Nogueira-Martins MF, Mariano M,. B-1 cell participation in T-cell-mediated alloimmune response. Immunobiology 2010; 215: 264.
18. DiLillo DJ, Griffiths R, Seshan SV, et al,. B lymphocytes differentially influence acute and chronic allograft rejection in mice. J Immunol 2011; 186: 2643.
19. Baldwin WM 3rd, Halushka MK, Valujskikh A, Fairchild RL,. B cells in cardiac transplants: from clinical questions to experimental models. Semin Immunol 2012; 24: 122.
20. Zarkhin V, Lovelace PA, Li L, Hsieh SC, Sarwal MM,. Phenotypic evaluation of B-cell subsets after rituximab for treatment of acute renal allograft rejection in pediatric recipients. Transplantation 2011; 91: 1010.
21. Reichardt P, Dornbach B, Rong S, et al,. Naive B cells generate regulatory T cells in the presence of a mature immunologic synapse. Blood 2007; 110: 1519.
22. Redfield RR 3rd, Rodriguez E, Parsons R, et al,. Essential role for B cells in transplantation tolerance. Curr Opin Immunol 2011; 23: 685.
23. Noorchashm H, Reed AJ, Rostami SY, et al,. B cell-mediated antigen presentation is required for the pathogenesis of acute cardiac allograft rejection. J Immunol 2006; 177: 7715.
24. Csencsits K, Wood SC, Lu G, et al,. Graft rejection mediated by CD4 + T cells via indirect recognition of alloantigen is associated with a dominant Th2 response. Eur J Immunol 2005; 35: 843.
25. Ye Q, Wang L, Wells AD, et al,. BAFF binding to T cell-expressed BAFF-R costimulates T cell proliferation and alloresponses. Eur J Immunol 2004a; 34: 2750.
26. Michelutti A, Gremese E, Morassi F, et al,. B-cell subsets in the joint compartments of seropositive and seronegative rheumatoid arthritis (RA) and No-RA arthritides express memory markers and ZAP70 and characterize the aggregate pattern irrespectively of the autoantibody status. Mol Med 2011; 17: 901.
27. Sagoo P, Perucha E, Sawitzki B, et al,. Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J Clin Invest. 2010; 120: 1848.
28. Viklicky O, Krystufkova E, Brabcova I, et al,. B-cell-related biomarkers of tolerance are up-regulated in rejection-free kidney transplant recipients. Transplantation 2013; 95: 148.
29. Zeglen S, Zakliczynski M, Wozniak-Grygiel E, et al,. Mixed cellular and humoral acute rejection in elective biopsies from heart transplant recipients. Transplant Proc 2009; 41: 3202.
30. Zakliczyński M, Zakliczyńska H, Klimczak A, et al,. Phenotypic characterisation of cellular infiltrates in endomyocardial biopsies of heart transplant recipients with diagnosed steroid resistant cellular rejection. Ann Transplant 2003; 8: 13.
31. Pirzada Y, Khuder S, Donabedian H,. Predicting AIDS-related events using CD4 percentage or CD4 absolute counts. AIDS Res Ther 2006; 3: 20.
32. Sarmiento E, Rodriguez-Molina JJ, Fernandez-Yañez J, et al,. IgG monitoring to identify the risk for development of infection in heart transplant recipients. Transpl Infect Dis. 2006; 8: 49.
33. Hilgendorf I, Mueller-Hilke B, Kundt G, et al,. The lack of memory B cells including T cell independent IgM+ IgD+ memory B cells in chronic graft-versus host disease is associated with susceptibility to infection. Transpl Int 2012; 25: 87.
34. Kuzmina Z, Greinix HT, Weigl R, et al,. Significant differences in B-cell subpopulations characterize patients with chronic graft-versus-host disease-associated dysgammaglobulinemia. Blood 2011; 117: 2265.
35. Tarantino G, Marco VD, Petta S, et al,. Serum BLyS/BAFF predicts the outcome of acute hepatitis C virus infection. J Viral Hepat 2009; 16: 397.